327 related articles for article (PubMed ID: 31419977)
1. Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis.
Moodley R; Suleman F
BMC Health Serv Res; 2019 Aug; 19(1):576. PubMed ID: 31419977
[TBL] [Abstract][Full Text] [Related]
2. The impact of the single exit price policy on a basket of generic medicines in South Africa, using a time series analysis from 1999 to 2014.
Moodley R; Suleman F
PLoS One; 2019; 14(7):e0219690. PubMed ID: 31365534
[TBL] [Abstract][Full Text] [Related]
3. Price comparison of high-cost originator medicines in European countries.
Vogler S; Zimmermann N; Babar ZU
Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):221-230. PubMed ID: 27658050
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the impact of single exit pricing (SEP) on medicine product withdrawal from the private healthcare market in South Africa.
Naidoo K; Suleman F
S Afr Med J; 2021 Apr; 111(5):444-447. PubMed ID: 34852886
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
6. Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa.
Mattila PO; Babar ZU; Suleman F
BMC Health Serv Res; 2021 Jul; 21(1):661. PubMed ID: 34229693
[TBL] [Abstract][Full Text] [Related]
7. Pseudo-Generics in South Africa: A Price Comparison.
Bangalee V; Suleman F
Value Health Reg Issues; 2019 Sep; 19():87-91. PubMed ID: 31357098
[TBL] [Abstract][Full Text] [Related]
8. Determinants of branded prescription medicine prices in OECD countries.
Kanavos PG; Vandoros S
Health Econ Policy Law; 2011 Jul; 6(3):337-67. PubMed ID: 21676345
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the effect of a proposed logistics fee cap on pharmaceuticals in South Africa--a pre and post analysis.
Bangalee V; Suleman F
BMC Health Serv Res; 2015 Nov; 15():522. PubMed ID: 26611893
[TBL] [Abstract][Full Text] [Related]
10. An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012.
Lee JSF; Sagaon Teyssier L; Dongmo Nguimfack B; Collins IJ; Lallemant M; Perriens J; Moatti JP
BMC Pediatr; 2016 Mar; 16():41. PubMed ID: 26979974
[TBL] [Abstract][Full Text] [Related]
11. Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology.
Sisay M; Amare F; Hagos B; Edessa D
J Pharm Policy Pract; 2021 Jul; 14(1):57. PubMed ID: 34225781
[TBL] [Abstract][Full Text] [Related]
12. Enhancing medicine price transparency through price information mechanisms.
Hinsch M; Kaddar M; Schmitt S
Global Health; 2014 May; 10():34. PubMed ID: 24885767
[TBL] [Abstract][Full Text] [Related]
13. [Risk sharing methods in middle income countries].
Inotai A; Kaló Z
Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
[TBL] [Abstract][Full Text] [Related]
14. The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis.
Rong X; Yin J; Duan S; Sun Q; Babar ZU
BMC Public Health; 2020 Apr; 20(1):588. PubMed ID: 32349722
[TBL] [Abstract][Full Text] [Related]
15. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
[TBL] [Abstract][Full Text] [Related]
16. The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period.
Wouters OJ; Sandberg DM; Pillay A; Kanavos PG
Soc Sci Med; 2019 Jan; 220():362-370. PubMed ID: 30513486
[TBL] [Abstract][Full Text] [Related]
17. Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Yang C; Jiang M; Zhao M; Ji W; Aziz MM; Khan FU; Gillani AH; Atif N; Fang Y; Babar ZUD
BMJ Open; 2020 Oct; 10(10):e034720. PubMed ID: 33033079
[TBL] [Abstract][Full Text] [Related]
18. Generic medicine pricing in Europe: current issues and future perspective.
Simoens S
J Med Econ; 2008; 11(1):171-5. PubMed ID: 19450118
[TBL] [Abstract][Full Text] [Related]
19. Value-based differential pricing: efficient prices for drugs in a global context.
Danzon P; Towse A; Mestre-Ferrandiz J
Health Econ; 2015 Mar; 24(3):294-301. PubMed ID: 24327269
[TBL] [Abstract][Full Text] [Related]
20. A pricing policy towards the sourcing of cheaper drugs in Cyprus.
Merkur S; Mossialos E
Health Policy; 2007 May; 81(2-3):368-75. PubMed ID: 16949176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
